vs

Side-by-side financial comparison of PHOTRONICS INC (PLAB) and Pennant Group, Inc. (PNTG). Click either name above to swap in a different company.

Pennant Group, Inc. is the larger business by last-quarter revenue ($289.3M vs $210.4M, roughly 1.4× PHOTRONICS INC). PHOTRONICS INC runs the higher net margin — 10.9% vs 3.0%, a 7.9% gap on every dollar of revenue. On growth, Pennant Group, Inc. posted the faster year-over-year revenue change (53.2% vs -5.5%). PHOTRONICS INC produced more free cash flow last quarter ($25.2M vs $17.4M). Over the past eight quarters, Pennant Group, Inc.'s revenue compounded faster (35.8% CAGR vs -3.8%).

Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.

The Pennant Group, Inc. is a U.S.-headquartered healthcare services provider that delivers home health care, hospice services, senior living solutions, and skilled nursing support. It operates across dozens of U.S. states, serving primarily elderly and medically vulnerable populations through its network of localized care facilities.

PLAB vs PNTG — Head-to-Head

Bigger by revenue
PNTG
PNTG
1.4× larger
PNTG
$289.3M
$210.4M
PLAB
Growing faster (revenue YoY)
PNTG
PNTG
+58.7% gap
PNTG
53.2%
-5.5%
PLAB
Higher net margin
PLAB
PLAB
7.9% more per $
PLAB
10.9%
3.0%
PNTG
More free cash flow
PLAB
PLAB
$7.8M more FCF
PLAB
$25.2M
$17.4M
PNTG
Faster 2-yr revenue CAGR
PNTG
PNTG
Annualised
PNTG
35.8%
-3.8%
PLAB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
PLAB
PLAB
PNTG
PNTG
Revenue
$210.4M
$289.3M
Net Profit
$22.9M
$8.6M
Gross Margin
33.7%
Operating Margin
22.9%
6.0%
Net Margin
10.9%
3.0%
Revenue YoY
-5.5%
53.2%
Net Profit YoY
-32.4%
50.0%
EPS (diluted)
$0.39
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PLAB
PLAB
PNTG
PNTG
Q4 25
$289.3M
Q3 25
$210.4M
$229.0M
Q2 25
$211.0M
$219.5M
Q1 25
$212.1M
$209.8M
Q4 24
$222.6M
$188.9M
Q3 24
$211.0M
$180.7M
Q2 24
$217.0M
$168.7M
Q1 24
$216.3M
$156.9M
Net Profit
PLAB
PLAB
PNTG
PNTG
Q4 25
$8.6M
Q3 25
$22.9M
$6.1M
Q2 25
$8.9M
$7.1M
Q1 25
$42.9M
$7.8M
Q4 24
$33.9M
$5.8M
Q3 24
$34.4M
$6.2M
Q2 24
$36.3M
$5.7M
Q1 24
$26.2M
$4.9M
Gross Margin
PLAB
PLAB
PNTG
PNTG
Q4 25
Q3 25
33.7%
Q2 25
36.9%
Q1 25
35.6%
Q4 24
37.0%
Q3 24
35.6%
Q2 24
36.5%
Q1 24
36.6%
Operating Margin
PLAB
PLAB
PNTG
PNTG
Q4 25
6.0%
Q3 25
22.9%
4.5%
Q2 25
26.4%
5.3%
Q1 25
24.6%
6.0%
Q4 24
25.1%
4.9%
Q3 24
24.7%
6.0%
Q2 24
25.8%
5.7%
Q1 24
26.6%
5.4%
Net Margin
PLAB
PLAB
PNTG
PNTG
Q4 25
3.0%
Q3 25
10.9%
2.7%
Q2 25
4.2%
3.2%
Q1 25
20.2%
3.7%
Q4 24
15.2%
3.0%
Q3 24
16.3%
3.4%
Q2 24
16.7%
3.4%
Q1 24
12.1%
3.1%
EPS (diluted)
PLAB
PLAB
PNTG
PNTG
Q4 25
$0.25
Q3 25
$0.39
$0.17
Q2 25
$0.15
$0.20
Q1 25
$0.68
$0.22
Q4 24
$0.54
$0.16
Q3 24
$0.55
$0.20
Q2 24
$0.58
$0.18
Q1 24
$0.42
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PLAB
PLAB
PNTG
PNTG
Cash + ST InvestmentsLiquidity on hand
$575.8M
Total DebtLower is stronger
$16.0K
$168.8M
Stockholders' EquityBook value
$1.1B
$374.3M
Total Assets
$1.8B
$968.2M
Debt / EquityLower = less leverage
0.00×
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PLAB
PLAB
PNTG
PNTG
Q4 25
Q3 25
$575.8M
Q2 25
$558.4M
Q1 25
$642.2M
Q4 24
$640.7M
Q3 24
$606.4M
Q2 24
$559.9M
Q1 24
$521.5M
Total Debt
PLAB
PLAB
PNTG
PNTG
Q4 25
$168.8M
Q3 25
$16.0K
$26.0M
Q2 25
$19.0K
$37.0M
Q1 25
$21.0K
$52.5M
Q4 24
$25.0K
$0
Q3 24
$28.0K
$108.9M
Q2 24
$2.5M
$82.2M
Q1 24
$2.7M
$83.3M
Stockholders' Equity
PLAB
PLAB
PNTG
PNTG
Q4 25
$374.3M
Q3 25
$1.1B
$343.0M
Q2 25
$1.1B
$333.6M
Q1 25
$1.1B
$323.0M
Q4 24
$1.1B
$312.0M
Q3 24
$1.1B
$187.3M
Q2 24
$1.0B
$173.0M
Q1 24
$1.0B
$164.2M
Total Assets
PLAB
PLAB
PNTG
PNTG
Q4 25
$968.2M
Q3 25
$1.8B
$753.6M
Q2 25
$1.7B
$751.4M
Q1 25
$1.7B
$743.6M
Q4 24
$1.7B
$679.5M
Q3 24
$1.6B
$646.8M
Q2 24
$1.6B
$602.5M
Q1 24
$1.6B
$578.2M
Debt / Equity
PLAB
PLAB
PNTG
PNTG
Q4 25
0.45×
Q3 25
0.00×
0.08×
Q2 25
0.00×
0.11×
Q1 25
0.00×
0.16×
Q4 24
0.00×
0.00×
Q3 24
0.00×
0.58×
Q2 24
0.00×
0.48×
Q1 24
0.00×
0.51×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PLAB
PLAB
PNTG
PNTG
Operating Cash FlowLast quarter
$50.1M
$21.0M
Free Cash FlowOCF − Capex
$25.2M
$17.4M
FCF MarginFCF / Revenue
12.0%
6.0%
Capex IntensityCapex / Revenue
11.8%
1.2%
Cash ConversionOCF / Net Profit
2.19×
2.43×
TTM Free Cash FlowTrailing 4 quarters
$64.5M
$36.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PLAB
PLAB
PNTG
PNTG
Q4 25
$21.0M
Q3 25
$50.1M
$13.9M
Q2 25
$31.5M
$34.6M
Q1 25
$78.5M
$-21.2M
Q4 24
$68.4M
$20.6M
Q3 24
$75.1M
$7.7M
Q2 24
$76.5M
$10.5M
Q1 24
$41.5M
$545.0K
Free Cash Flow
PLAB
PLAB
PNTG
PNTG
Q4 25
$17.4M
Q3 25
$25.2M
$10.5M
Q2 25
$-29.1M
$31.6M
Q1 25
$43.3M
$-23.2M
Q4 24
$25.2M
$17.2M
Q3 24
$50.7M
$6.8M
Q2 24
$56.5M
$8.9M
Q1 24
$-1.8M
$-2.6M
FCF Margin
PLAB
PLAB
PNTG
PNTG
Q4 25
6.0%
Q3 25
12.0%
4.6%
Q2 25
-13.8%
14.4%
Q1 25
20.4%
-11.1%
Q4 24
11.3%
9.1%
Q3 24
24.0%
3.8%
Q2 24
26.0%
5.3%
Q1 24
-0.8%
-1.7%
Capex Intensity
PLAB
PLAB
PNTG
PNTG
Q4 25
1.2%
Q3 25
11.8%
1.5%
Q2 25
28.7%
1.4%
Q1 25
16.6%
0.9%
Q4 24
19.4%
1.8%
Q3 24
11.6%
0.5%
Q2 24
9.2%
1.0%
Q1 24
20.0%
2.0%
Cash Conversion
PLAB
PLAB
PNTG
PNTG
Q4 25
2.43×
Q3 25
2.19×
2.29×
Q2 25
3.55×
4.89×
Q1 25
1.83×
-2.73×
Q4 24
2.02×
3.57×
Q3 24
2.18×
1.24×
Q2 24
2.11×
1.84×
Q1 24
1.59×
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PLAB
PLAB

High End Integrated Circuits$53.6M25%
High End Flat Panel Displays$53.5M25%
KR$43.7M21%
Other$42.1M20%
Mainstream Flat Panel Displays$9.1M4%
Transferred At Point In Time$8.4M4%

PNTG
PNTG

Home Health Subsegment$136.2M47%
Hospice Subsegment$97.1M34%
Private And Other$36.4M13%
Medicare And Medicaid$19.6M7%
Affiliated Entity$2.2M1%

Related Comparisons